Clarithromycin
Product Images NDC 33261-631

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 33261-631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Clarithromycin 250mg Tab 500mg Tab For Wockhardt 1)

Chemical structure of clarithromycin showing its macrolide ring with multiple hydroxyl, methyl, and methoxy groups attached, along with a dimethylamine functional group, as displayed in the image.*

FDA Label Image

Survival Graph (Clarithromycin 250mg Tab 500mg Tab For Wockhardt 2)

A survival curve graph comparing the proportion of subjects surviving over days since randomization for Clarithromycin and placebo groups. The x-axis represents days since randomization, ranging from 0 to around 700, and the y-axis represents the proportion surviving, from 0 to 1. The graph shows two lines: a solid line for Clarithromycin and a dotted line for placebo, illustrating survival trends over time.*

FDA Label Image

Image Label (Clarithromycin 250mg Tab 500mg Tab For Wockhardt 3)

Clarithromycin 250 mg film-coated tablets label from Aidarex Pharmaceuticals LLC. The label states 20 tablets per package, generic for Biaxin, with a white oval tablet imprinted with 'M 0954' on one side. Manufactured by Wockhardt Limited, Mumbai, India. Includes NDC 33261-0631-20 and instructions for dosing frequency.*

FDA Label Image

Image Label (Clarithromycin 250mg Tab 500mg Tab For Wockhardt 4)

Label for Clarithromycin 500 mg tablets by Aidarex Pharmaceuticals LLC. The package contains 20 film-coated, white oval tablets. It specifies the active ingredient as Clarithromycin 500 mg per tablet. Markings include the drug's generic name, NDC 33261-0618-20, and manufacturer Woockhardt Ltd., Mumbai, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.